Teva Pharmaceutical Industries Ltd. ADR-0.06% $20.31B ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 45,050.15 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

Aditya Birla SL ELSS Tax Saver Fund (IDCW) 262.21 9,53,316 1.53 Aditya Birla SL ELSS Tax Saver Fund (G) 262.21 9,53,316 1.53 Aditya Birla SL ELSS Tax Saver Fund ...

GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting ... told Fierce Pharma it’s aware of the litigation ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Flagship Pioneering has signed yet another strategic-level deal with a big pharma group, with GSK the latest to tap into its network of biotech companies in an alliance that could be worth more ...

With Gilead Sciences sprinting to a likely approval next year for its long-acting pre-exposure prophylaxis (PrEP) drug for HIV, the California company has a chance to one-up GSK. While the British ...

Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.

Read also: GlaxoSmithKline Pharma appoints Dr Shalini Menon as Executive Vice President - Medical Affairs Moderna earned $6.7 billion in revenue from Spikevax last year. Pfizer made $11.2 billion from ...

Hyundai IPO retail subscription was the worst among biggest 5 offers in India (50%). Expensive pricing (26x PE vs industry average of 24.41x) dampened retail investor sentiment.